Company / Working Capital per Share
Halozyme Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.26
FY2025
5-year range
$4.42 / $7.46
FY2021-FY2025
Trend
-29.5%
vs FY2024
Sector context
#108 of 210
Health Care
What the data says
At $5.26, Halozyme's working capital per share ranks #108 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.98 in FY2020 to $7.46 in FY2024.
Based on SEC 10-K filings.
5.26 in FY2025 with a 5-year CAGR of +40.1%.
Improved from $4.69 to $5.26 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- +40.1%
- 10-Year CAGR
- -
Sector benchmark
#108 of 210 in Health CareTop 51% of 210This company $5.26 Sector average $118.60
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 29.5% year-over-year.
- Ranks #108 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.26 | -29.5% |
| FY2024 | $7.46 | +59.1% |
| FY2023 | $4.69 | +6.0% |
| FY2022 | $4.42 | -26.2% |
| FY2021 | $5.99 | +514.2% |
| FY2020 | $0.98 | -69.2% |
| FY2019 | $3.16 | +62.2% |
| FY2018 | $1.95 | -33.4% |
| FY2017 | $2.93 | +85.7% |
| FY2016 | $1.58 | +81.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026